Alternate sources and substitutes for therapeutic blood components

R. A. Kahn, R. W. Allen, J. Baldassare

Research output: Contribution to journalReview article

23 Scopus citations

Abstract

With the rapid advancement of technology, blood substitutes and alternate sources of therapeutic blood components are likely to become available, although not for a number of years. Within five to eight years, at least some plasma derivatives probably will be replaced by alternate sources using recombinant DNA technology; substitutes for RBCs and platelets will be much more difficult to develop. Availability of these products will have far-reaching effects on our health care system and it is probably not too soon to anticipate the effects and plan for the consequences.

Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalBlood
Volume66
Issue number1
Publication statusPublished - 1 Dec 1985

    Fingerprint

Cite this